<?xml version="1.0" encoding="UTF-8"?>
<p>Blood samples can be collected for both nucleic acid testing and serological testing. Testing of virus from blood samples could be an effective way to monitor viremia. SARS‐CoV RNA was detected in 50% of plasma and 78% of serum samples during the first week of illness.
 <xref rid="rmv2106-bib-0053" ref-type="ref">
  <sup>53</sup>
 </xref> High‐SARS‐CoV viral load in serum correlated with oxygen desaturation, mechanical ventilation, and death.
 <xref rid="rmv2106-bib-0049" ref-type="ref">
  <sup>49</sup>
 </xref> About 33% of serum samples yielded MERS‐CoV RNA at initial diagnosis, and were associated with a worse clinical course.
 <xref rid="rmv2106-bib-0051" ref-type="ref">51</xref>, 
 <xref rid="rmv2106-bib-0054" ref-type="ref">54</xref> Patients with detectable SARS‐CoV‐2 RNA in the blood progressed to severe symptom stage, indicating a strong correlation of serum viral RNA with the disease severity.
 <xref rid="rmv2106-bib-0055" ref-type="ref">
  <sup>55</sup>
 </xref> In keeping with SARS‐CoV and MERS‐CoV,
 <xref rid="rmv2106-bib-0053" ref-type="ref">53</xref>, 
 <xref rid="rmv2106-bib-0056" ref-type="ref">56</xref> plasma/serum SARS‐CoV‐2 quantification could also represent a potentially useful early diagnostic and prognostic tool.
</p>
